217 related articles for article (PubMed ID: 16362081)
1. Leptin and cardiovascular diseases.
Luo JD; Zhang GS; Chen MS
Drug News Perspect; 2005 Sep; 18(7):427-31. PubMed ID: 16362081
[TBL] [Abstract][Full Text] [Related]
2. Leptin and cardiovascular diseases.
Luo JD; Zhang GS; Chen MS
Timely Top Med Cardiovasc Dis; 2005 Dec; 9():E34. PubMed ID: 16404479
[TBL] [Abstract][Full Text] [Related]
3. Leptin signaling and obesity: cardiovascular consequences.
Yang R; Barouch LA
Circ Res; 2007 Sep; 101(6):545-59. PubMed ID: 17872473
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension.
Baltatzi M; Hatzitolios A; Tziomalos K; Iliadis F; Zamboulis Ch
Int J Clin Pract; 2008 Sep; 62(9):1432-40. PubMed ID: 18793378
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin, ghrelin, and leptin differentially influence human platelet and human vascular endothelial cell functions: implication in obesity-associated cardiovascular diseases.
Elbatarny HS; Netherton SJ; Ovens JD; Ferguson AV; Maurice DH
Eur J Pharmacol; 2007 Mar; 558(1-3):7-13. PubMed ID: 17207790
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular consequences of obesity.
Okerberg K; Hamilton Dougherty A
Curr Womens Health Rep; 2003 Apr; 3(2):110-5. PubMed ID: 12628080
[TBL] [Abstract][Full Text] [Related]
7. Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome.
Correia ML; Rahmouni K
Diabetes Obes Metab; 2006 Nov; 8(6):603-10. PubMed ID: 17026484
[TBL] [Abstract][Full Text] [Related]
8. Leptin and the clinical cardiovascular risk.
Singh M; Bedi US; Singh PP; Arora R; Khosla S
Int J Cardiol; 2010 Apr; 140(3):266-71. PubMed ID: 19944469
[TBL] [Abstract][Full Text] [Related]
9. Relationship between metabolic syndrome and platelet responsiveness to leptin in overweight and obese patients.
Corica F; Corsonello A; Lucchetti M; Malara A; De Domenico D; Cannavò L; Foti S; Valenti A; Ientile R; Saitta A
Int J Obes (Lond); 2007 May; 31(5):842-9. PubMed ID: 17047640
[TBL] [Abstract][Full Text] [Related]
10. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1.
Rajapurohitam V; Javadov S; Purdham DM; Kirshenbaum LA; Karmazyn M
J Mol Cell Cardiol; 2006 Aug; 41(2):265-74. PubMed ID: 16806260
[TBL] [Abstract][Full Text] [Related]
11. Increased cardiovascular risk markers in obesity are associated with body adiposity: role of leptin.
Gómez-Ambrosi J; Salvador J; Silva C; Pastor C; Rotellar F; Gil MJ; Cienfuegos JA; Frühbeck G
Thromb Haemost; 2006 Jun; 95(6):991-6. PubMed ID: 16732378
[TBL] [Abstract][Full Text] [Related]
12. Cardiac autonomic nervous system activity in obesity.
Liatis S; Tentolouris N; Katsilambros N
Pediatr Endocrinol Rev; 2004 Aug; 1 Suppl 3():476-83. PubMed ID: 16444178
[TBL] [Abstract][Full Text] [Related]
13. Untangling the heavy cardiovascular burden of obesity.
Lavie CJ; Milani RV; Ventura HO
Nat Clin Pract Cardiovasc Med; 2008 Jul; 5(7):428-9. PubMed ID: 18521107
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risk factors in young, overweight, and obese European adults and associations with physical activity and omega-3 index.
Ramel A; Pumberger C; Martinéz AJ; Kiely M; Bandarra NM; Thorsdottir I
Nutr Res; 2009 May; 29(5):305-12. PubMed ID: 19555811
[TBL] [Abstract][Full Text] [Related]
15. Obesity-associated hypertension: new insights into mechanisms.
Rahmouni K; Correia ML; Haynes WG; Mark AL
Hypertension; 2005 Jan; 45(1):9-14. PubMed ID: 15583075
[TBL] [Abstract][Full Text] [Related]
16. Leptin and cardiovascular diseases.
Hou N; Luo JD
Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):905-13. PubMed ID: 21957899
[TBL] [Abstract][Full Text] [Related]
17. Leptin in end stage renal disease (ESRD): a link between fat mass, bone and the cardiovascular system.
Mallamaci F; Tripepi G; Zoccali C
J Nephrol; 2005; 18(4):464-8. PubMed ID: 16245256
[TBL] [Abstract][Full Text] [Related]
18. [Leptin--adipose tissue hormone and its role in cardiovascular diseases].
Racek-Król B
Pol Merkur Lekarski; 2006 Jun; 20(120):713-6. PubMed ID: 17007277
[TBL] [Abstract][Full Text] [Related]
19. Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis.
Kshatriya S; Reams GP; Spear RM; Freeman RH; Dietz JR; Villarreal D
Curr Opin Nephrol Hypertens; 2010 Jan; 19(1):72-8. PubMed ID: 19851106
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
